Infalin Duo

Ciprofloxacin, the active ingredient in Infalin Duo, is a fluoroquinolone antibiotic presented as a topical otic preparation for ear use. It treats bacterial ear infections such as otitis externa in both adults and children. Fluocinolone acetonide, also present, provides anti‑inflammatory action to reduce swelling and pain.

GNH USA supplies Infalin Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infalin Duo combines an antibiotic and a corticosteroid to address bacterial and inflammatory conditions of the external ear. - Otitis externa: reduces bacterial load and inflammation, promoting faster resolution of infection. - Acute bacterial ear infection: provides targeted antimicrobial activity while controlling local swelling. - Chronic ear canal inflammation: helps manage persistent inflammation after infection clearance.

Infalin Duo may cause local or systemic adverse reactions.

Common Side Effects: - Ear discomfort or mild burning sensation. - Itching or mild irritation of the ear canal. - Temporary hearing changes or muffled sound. - Mild headache. - Local dryness or flaking skin.

Serious or Rare Side Effects: - Allergic reaction such as rash, swelling, or anaphylaxis. - Ototoxicity leading to permanent hearing loss. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Vision changes if medication spreads to the eye. - Unusual bleeding or bruising.

Before using Infalin Duo, consider the following safety measures. - Assess tympanic membrane integrity: avoid use if perforation is present. - Hypersensitivity: discontinue if allergic reaction occurs. - Viral infections: do not use unless bacterial superinfection is confirmed. - Monitor for signs of ototoxicity, especially with prolonged use. - Avoid concurrent ototoxic ear preparations. - Store at room temperature: keep in original container, protect from moisture and light.

Infalin Duo may interact with other medications; awareness helps prevent complications.

Major Interactions (Avoid): - Concurrent ototoxic ear drops (e.g., aminoglycoside preparations): increased risk of hearing loss. - Systemic fluoroquinolones: additive risk of tendon toxicity.

Moderate Interactions (Monitor Closely): - Corticosteroid eye drops: potential for increased systemic steroid exposure. - Anticoagulants: rare increase in bleeding risk with systemic absorption. - Non‑steroidal anti‑inflammatory drugs: may heighten gastrointestinal irritation if absorbed.